Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)

Historical Holders from Q3 2024 to Q3 2025

Symbol
FBRX on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
12.5M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
10.3M
Holdings value
$155M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
42
Number of buys
27
Number of sells
-10
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FEDERATED HERMES, INC. 13.15% +10.5% $18.7M $1.79M 1.64M +10.6% Federated Hermes, Inc. 30 Sep 2025
ALGER ASSOCIATES INC 13.1% -1.54% $24.5M $234K 1.63M +0.96% Alger Associates, Inc. 30 Sep 2025
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 9.99% 0% $13.4M $6.62M 1.27M +97.9% TYBOURNE CAPITAL MANAGEMENT (HK) LTD 30 Jun 2025
Affinity Asset Advisors, LLC 6.9% $16.4M 862K Affinity Asset Advisors, LLC 17 Dec 2025
JANUS HENDERSON GROUP PLC 9.9% 0% $6.94M 658K 0% JANUS HENDERSON GROUP PLC 30 Jun 2025
Ikarian Capital, LLC 4.99% -45.1% $6.52M $89.1K 618K +1.39% Ikarian Capital, LLC 30 Jun 2025
ORBIMED ADVISORS LLC 8% $3.76M 510K ORBIMED ADVISORS LLC 31 Dec 2024
Oliveira Steven Michael 6.76% $3.19M 432K Nemean Asset Management, LLC 20 Nov 2024
PERCEPTIVE ADVISORS LLC 2.5% $1.21M 164K Perceptive Advisors LLC 31 Dec 2024
BIOTECHNOLOGY VALUE FUND L P 0.5% -94.9% $980K -$8.67M 65.4K -89.8% BVF PARTNERS L P/IL 30 Sep 2025
BOOTHBAY FUND MANAGEMENT, LLC 0.8% -86.7% $567K -$369K 53.8K -39.4% Boothbay Fund Management, LLC 30 Jun 2025

Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 10.3M $155M +$6.73M $15.00 42
2025 Q2 9.81M $127M +$62.3M $12.93 33
2025 Q1 5.03M $39.3M +$4.7M $7.76 29
2024 Q4 4.28M $97.1M +$81.9M $22.71 26
2024 Q3 737K $4.12M +$4.08M $5.59 23